ACE inhibitor in complex therapy of functional class II-III chronic heart failure in patients with chronic obstructive pulmonary disease

QR Code

ACE inhibitor in complex therapy of functional class II-III chronic heart failure in patients with chronic obstructive pulmonary disease

.

Saved in:

Bibliographic Details
Main Authors:	A. G. Evdokimova, A. E. Radzevich, N. O. Kuvyrdina, O. I. Tereshchenko, E. V. Kovalenko, N. V. Churkina, T. A. Komissarova, V. V. Evdokimov, N. I. Shakhova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2005-12-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2341
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Monocinque clinical effectiveness in complex treatment of patients with chronic heart failure, functional class II-III angina, and chronic obstructive pulmonary disease
by: A. G. Evdokimova, et al.
Published: (2007-04-01)

Nebivolol in complex treatment of patients with coronary heart disease and chronic obstructive pulmonary disease
by: A. G. Evdokimova, et al.
Published: (2007-02-01)

Clinical efficacy of nebivolol and metoprolol in complex treatment of patients with coronary heart disease and II-III functional class chronic heart failure
by: A. G. Evdokimova, et al.
Published: (2005-04-01)

COMPARATIVE EFFICACY OF ACE INHIBITORS (RAMIPRIL VS ENALAPRIL) IN TREATMENT OF CHRONIC HEART FAILURE IN WOMEN
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Effectiveness of the long-term therapy with bronchodilators, fenspiride and an ACE inhibitor perindopril among patients with chronic obstructive pulmonary disease and chronic cor pulmonale
by: R. G. Bakaev, et al.
Published: (2010-10-01)

Optimization of the Treatment of Patients with Chronic Cardiac Insufficiency and Cardiopulmonary Pathology
by: A. G. Evdokimova, et al.
Published: (2020-05-01)

Clinical, cardio-hemodynamical, and respiratory effects of ACE inhibitor cilazapril in patients with arterial hypertension and chronic obstructive pulmonary disease
by: L. I. Olbynskaya, et al.
Published: (2005-02-01)

ACE inhibitors in patients with acute myocardial infarction
by: S. N. Tereshchenko, et al.
Published: (2005-08-01)

Optimization of Treatment of Patients with Chronic Cardiac Insufficiency of the Ischemic Genesis and Hobnail Liver
by: A. G. Evdokimova, et al.
Published: (2020-05-01)

MICROCIRCULATION IN CHRONIC HEART FAILURE PATIENTS TREATED WITH ACE INHIBITORS AND DIURETICS
by: Yu. I. Gurfinkel, et al.
Published: (2011-04-01)

Decision rule for stratification of patients with chronic heart failure of functional class II and III
by: E. V. Samoilova, et al.
Published: (2020-04-01)

Comparative effectiveness of ACE inhibitors spirapril, fosinopril, and enalapril in complex therapy of patients with coronary heart disease, chronic obstructive pulmonary disease, and arterial hypertension
by: M. A. Popova, et al.
Published: (2006-06-01)

THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE
by: S. N. Tereshchenko, et al.
Published: (2015-12-01)

Ivabradine therapy effectiveness in patients with chronic heart failure, Functional Class III
by: S. G. Kanorskiy, et al.
Published: (2011-04-01)

Nebivolol in complex therapy of patients with coronary heart disease and chronic heart failure
by: A. G. Yevdokimova, et al.
Published: (2004-08-01)

ACE INHIBITOR ZOFENOPRIL IN COMPLEX THERAPY OF CHRONIC HEART FAILURE AND DILATED CARDIOMYOPATHY
by: Z. T. Astakhova, et al.
Published: (2010-04-01)

ACE inhibitors in arterial hypertension management: zofenopril – class-specific effects and extra benefits
by: V. S. Zadionchenko, et al.
Published: (2007-04-01)

EVIDENCE-BASED CHOICE OF ACE INHIBITORS
by: G. E. Gendlin, et al.
Published: (2012-08-01)

ACE inhibitor lisinopril influence on left ventricular diastolic dysfunction and endothelial response in hypertensive patients with or without chronic heart failure
by: A. D. Kuimov, et al.
Published: (2004-06-01)

SIGNIFICANCE OF BASELINE ACE ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME WHEN ADMINISTRATION OF ACE INHIBITORS AND IMIDAZOLINE AGONISTS IS CONSIDERED
by: T. V. Aparina, et al.
Published: (2001-04-01)

METHOD FOR THE PREDICTION OF THE DEVELOPMENT OF CHRONIC PULMONARY HEART IN COAL WORKERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: O. Yu. Korotenko, et al.
Published: (2013-05-01)

Clinical study of Russian class III antiarrhythmic agent, nibentan, in supraventricular arrhythmia management
by: V. G. Valiev, et al.
Published: (2005-12-01)

Features of the clinical course of chronic pancreatitis in patients with chronic obstructive pulmonary disease
by: O. S. Khukhlina, et al.
Published: (2024-02-01)

Emphysema diagnostics in patients with chronic obstructive lung disease
by: E. V. Ekkardt, et al.
Published: (2010-10-01)

ACE inhibitors in patients with heart failure
by: O. P. Shevchenko, et al.
Published: (2008-10-01)

CLINICAL AND IMMUNOLOGICAL ASPECTS OF CHRONIC OBSTRUCTIVE LUNG DISEASE
by: T. O. Kostrova, et al.
Published: (2014-07-01)

Influence of therapy chronic heart failure of functional class III on regulatory adaptive status
by: E. S. Rokotyanskaya
Published: (2014-10-01)

The Importance of Chronic Bronchitis in Chronic Obstructive Pulmonary Disease
by: Sapey, Elizabeth, et al.
Published: (2011)

Chronic obstructive pulmonary disease and chronic heart failure in elderly people: literature review
by: V. A. Gubkina, et al.
Published: (2016-06-01)

NEW EVALUATION METHOD FOR EFFICACY OF HYPOTENSIVE TREATMENT WITH ACE INHIBITORS
by: V. V. Shkarin, et al.
Published: (2003-06-01)

Features of pancreatic parenchyma fibrosis in the comorbid course of chronic pancreatitis and chronic obstructive pulmonary disease
by: I.V. Dudka, et al.
Published: (2024-12-01)

CHRONIC HEART FAILURE OF ISCHEMIC ORIGIN: ROLE OF CHRONIC PULMONARY OBSTRUCTIVE DISEASE
by: N. T. Vatutin, et al.
Published: (2016-08-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

EARLY DETECTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE — VECTOR ON BIOMARKERS
by: V. I. Shevcova, et al.
Published: (2016-08-01)

Pharmacology of modern ACE inhibitors: moexipril example
by: D. P. Khloponin, et al.
Published: (2007-10-01)

Spirapril – a modern ACE inhibitor
by: V. M. Gorbunov
Published: (2005-06-01)

Beta-adrenoЬlockers in patients with chronic heart failure and chronic obstructive pulmonary disease
by: M. E. Statsenko, et al.
Published: (2008-12-01)

New potential of ACE inhibitors in clinical practice
by: D. V. Nebieridze, et al.
Published: (2010-10-01)

Problems of diagnosis and treatment of chronic ischaemic heart disease combined with chronic obstructive pulmonary disease according to retrospective analysis
by: V.A. Potabashnii, et al.
Published: (2021-06-01)

NEUROHUMORAL ASPECTS OF FORMATION OF COR PULMONALE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASES
by: T. A. Fyodorova, et al.
Published: (2003-12-01)